IR-1061: Harnessing Near Infrared Fluorescent Dye for Deep Tissue Imaging

Principle and Setup: Why IR-1061 Transforms In Vivo Optical Imaging

Fluorescence imaging in the near-infrared (NIR) window has fundamentally shifted the landscape of in vivo biomedical research. IR-1061, supplied by APExBIO, exemplifies this transformation as a near infrared fluorescent dye tailored for deep tissue and vascular imaging. With a maximal emission near 1064 nm and a quantum yield (QY) of 1.7%—surpassing most cyanines and carbon nanotubes—IR-1061 enables high-sensitivity, low-background imaging in the NIR-II window (1000–1700 nm) (source: paper).

The key to IR-1061’s performance lies in its optimized hydrophobic cyanine structure, which reduces photon scattering and biological autofluorescence, thereby facilitating superior deep tissue penetration and spatial resolution for vascular and organ-level imaging (source: hyperfluor.com). However, its unique solubility profile—high solubility in DMSO (≥25.65 mg/mL), but insoluble in ethanol or water—requires careful handling and preparation for consistent results (source: product_spec).

Step-by-Step Workflow: Maximizing IR-1061 Performance in Experimental Protocols

Deploying IR-1061 as a fluorescent dye for in vivo imaging demands attention to solubilization, encapsulation, and delivery parameters:

1. Stock Solution Preparation: Dissolve IR-1061 in DMSO at concentrations up to 25.65 mg/mL. Avoid ethanol or water, as IR-1061 is insoluble in these solvents (source: product_spec).
2. Encapsulation: For optimal in vivo fluorescence, encapsulate IR-1061 in anionic liposomes or polymeric nanoparticles. The reference study demonstrated that anionic liposomal formulations maximize fluorescence intensity and retention, while cationic liposomes lead to poor encapsulation and reduced signal (source: paper).
3. Aggregate State Management: Monitor dye loading to maintain IR-1061 in its free state within the carrier. Excessive loading promotes aggregation, quenching fluorescence and reducing imaging efficacy (source: paper).
4. Injection and Imaging: Administer freshly prepared IR-1061 formulations intravenously. Initiate imaging in the NIR-II window (1000–1700 nm) to exploit its deep tissue clarity, ideally within 30–60 minutes post-injection for angiography and tissue mapping (workflow_recommendation).

Protocol Parameters

• stock solution preparation | 25.65 mg/mL in DMSO | Solubilization for all assays | Ensures maximal dye availability and prevents precipitation | product_spec
• liposome charge selection | anionic phospholipids | In vivo vascular and tissue imaging | Maximizes encapsulation efficiency and fluorescence intensity | paper
• dye loading in carrier | ≤ 0.5 mg/mL (final liposome concentration) | Prevents aggregation and maintains high QY | Higher concentrations risk fluorescence quenching | paper
• storage temperature | -20°C (solid, dry) | Long-term stock preservation | Prevents degradation, ensures batch-to-batch reproducibility | product_spec
• imaging window post-injection | 0–16 hours | Angiography, dynamic vascular studies | Maintains high signal over extended imaging periods | paper

Key Innovation from the Reference Study

Yu et al. (2021) introduced a rational design strategy for NIR-II fluorescent nanosystems, pinpointing the interplay between liposome charge and IR-1061 encapsulation as the critical determinant of imaging performance. Their systematic analysis found that anionic liposomes not only encapsulate IR-1061 more efficiently but also sustain higher fluorescence intensity and longer signal retention in vivo (source: paper). This insight translates directly to practical assay choices: always prioritize anionic lipid or biocompatible polymer carriers for IR-1061 delivery, and titrate dye loading to avoid aggregate formation that dampens signal. The study’s demonstration of clear, high-resolution angiography for more than 16 hours post-administration sets a new benchmark for vascular imaging workflows.

Advanced Applications and Comparative Advantages

IR-1061’s unique photophysical and solubility properties underpin several advanced applications in biomedical research:

• Long-Circulation Angiography: IR-1061-liposome systems enable prolonged vascular imaging, supporting dynamic studies of blood flow, vessel integrity, and disease progression (source: paper).
• Deep Tissue Tumor Imaging: The NIR-II emission ensures clear delineation of tumors beneath several millimeters of tissue, outperforming traditional visible/NIR-I dyes in penetration and contrast (source: distearoyl-sn-glycero.com).
• Intraoperative Guidance: IR-1061’s high signal-to-noise ratio and fast clearance profile make it suitable for real-time surgical navigation, minimizing background for precise resection (workflow_recommendation).
• Comparative Biocompatibility: Unlike inorganic quantum dots or rare-earth doped nanoparticles, IR-1061’s organic nature offers a safer profile for translation, with faster systemic clearance and reduced long-term tissue retention (source: paper).

For a broader understanding of how nanoparticle formulation further enhances IR-1061’s imaging capabilities, see "Polystyrene Nanoparticles Enhance IR-1061 NIR Imaging for Deep Tissue". This article complements the reference study by exploring alternative encapsulation strategies—polystyrene nanoparticles—that further refine polarity and surface chemistry for robust in vivo performance. For a protocol-driven guide to polymer-based IR-1061 encapsulation and troubleshooting, "IR-1061: Redefining Deep Tissue Imaging with NIR-II Fluorescence" provides extended workflow optimization and safety perspectives, directly extending the core findings of Yu et al. (2021).

Troubleshooting and Optimization Tips

• Solubility Pitfalls: Always use DMSO for stock preparation; attempts with water or ethanol will result in undissolved dye and inconsistent loading (source: product_spec).
• Aggregation Control: If fluorescence intensity drops, verify that dye concentration within liposomes/nanoparticles is within empirically supported ranges (≤0.5 mg/mL). Higher loadings risk aggregate-induced quenching (source: paper).
• Carrier Optimization: For new applications, start with anionic liposomes or neutral polymeric carriers. Cationic formulations should be avoided unless justified by specific targeting requirements, as they show inferior encapsulation and signal (source: paper).
• Storage Practice: Prepare working solutions fresh before each use. Long-term storage of dissolved IR-1061 leads to signal degradation; always store the solid dye at -20°C in a sealed, desiccated container (source: product_spec).
• Imaging Calibration: Regularly calibrate NIR-II imaging equipment and verify that filter sets match IR-1061’s emission profile for optimal signal capture (workflow_recommendation).

Future Outlook: Expanding the Role of IR-1061 in Biomedical Imaging

The rational design of IR-1061-based nanosystems has firmly established this near infrared fluorescent dye as a benchmark for in vivo imaging platforms. Ongoing advances in carrier engineering—guided by the interplay of electrostatics and dye loading—will likely yield even greater control over biodistribution, signal retention, and safety (source: paper). The demonstrated ability of IR-1061 systems to support long-term, high-contrast angiography and deep tissue visualization opens new frontiers in intraoperative imaging, hemodynamic evaluation, and the quantification of microvascular disease. While continued comparative studies with novel carriers and real-world clinical validation are needed, the foundation laid by APExBIO’s quality-controlled IR-1061 positions it as a go-to choice for researchers seeking reliable, high-performance NIR-II imaging agents.

For further in-depth protocol recommendations and comparative perspectives, "IR-1061 as a Benchmark Near Infrared Fluorescent Dye for Deep Imaging" contrasts molecular engineering and assay decision-making, complementing the current workflow-focused approach.